Prof. Giuseppe Opocher
Scientific Director IOV
Project manager
tel. 049 821 5644 I 7418

Dott.ssa Annarosa del Mistro
IOV Referent for WP 5
Project coordinator for the IOV-IRCCS
tel. 049 821 5872

Dott.ssa Arcangela De Nicolo
IOV Referent for WP 6

Prof. Antonio Rosato
IOV Referent for WP 9

Dott. Alberto Bortolami
IOV Referent for WP 10

Grant office
tel. 049 821 5187

In the European Union, cancer continues to represent one of the main challenges for public health. In the last 8 years, activities to combat this disease have been intensified in several respects, but some important issues remain unresolved.

The Innovative Partnership for Action Against Cancer – iPAAC, selected for funding under the Third Health Programme 2014–2020, aims to build upon the outcomes of previous EPAAC and CANCON Joint Actions. The IOV-IRCCS is among the 8 Italian institutions that collaborate with the Istituto Superiore di Sanità (one of the 24 beneficiaries of the grant agreement) through participation in the following work packages:

  • WP 5: Cancer prevention
  • WP 6: Genomics in cancer control and care
  • WP 9: Innovative therapies in cancer
  • WP 10: Governance of integrated and comprehensive cancer care


The general objective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. They include:

  • advances in the field of prevention;
  • global approaches to the use of genomics in cancer control;
  • enhancement of information systems and cancer registers;
  • improving care with a focus on major challenges;
  • anticipation of the upcoming challenges in terms of innovative therapies and the management of integrated cancer control, including a new analysis of national cancer plans.

Expected results

  • Support to member countries in the implementation at regional and local level of the recommendations of iPAAC and CANCON;
  • strengthening of cancer prevention;
  • greater effectiveness in the management of neglected tumors;
  • support for the introduction of immunotherapies;
  • evaluation of cancer care in member countries;
  • support for legislators involved in governance;
  • strengthening of information systems on a population basis.